Abstract:Induction of pluripotent stem cells from somatic cells by defined factors was shown to be possible only recently, but already several laboratories have made tremendous strive toward improving and understanding the process. Originally, Oct4, Sox2, Klf4, and cMyc were identified as being the combination of genes necessary to induce reprogramming. It was later shown that cMyc was dispensable; however, in its absence the process was less efficient and took a considerably longer period of time to occur. Furthermore, others have shown that the combination of Oct4, Sox2, Nanog, and Lin28 could also induce reprogramming. One major caveat associated with these techniques remains the need for overexpression of several genes using viral systems. Until very recently, most studies were done using integrating viruses such as retroviruses and lentiviruses. This method ensured that the protein of interested would be expressed at a high concentration and for an adequate period of time necessary to induce reprogramming. Up to date, others have now been able to use different nonintegrative method such as adenovirus and plasmid transfection to induce reprogramming. Furthermore, piggyBac transposition was successfully used to induce reprogramming of murine cells. Most importantly, it was recently published that reprogramming can be induced in the absence of virus, with proteins and small molecules. All of the later methods are appealing since they do not require the integration of the virus or plasmid to exert its effect. However, one avenue that would be all the more therapeutically appealing would be to induce reprogramming in the absence of gene overexpression systems, using small molecules to modulate signaling pathways in the somatic cells. A few molecules have already been identified with the ability to either improve the process or replace one or two of the genes deemed necessary for reprogramming. We have screened successfully for compounds that can replace some of these factors, and share the methods developed following these screens.

Activation of Pluripotency Genes in Human Fibroblast Cells by a Novel Mrna Based Approach

Pluripotent state induction in mouse embryonic fibroblast using mRNAs of reprogramming factors

Brief Report: Combined Chemical Treatment Enables Oct4-Induced Reprogramming from Mouse Embryonic Fibroblasts

Cellular Reprogramming by in vitro Transcribed mRNA Cocktail of Oct4,Sox2 and SV40 T-antigen

Harnessing Endogenous Transcription Factors Directly by Small Molecules for Chemically Induced Pluripotency Inception.

Direct Reprogramming of Mouse Fibroblasts to Neural Progenitors

Generation of Human-Induced Pluripotent Stem Cells in the Absence of Exogenous Sox2

Pharmacological Reprogramming of Fibroblasts into Neural Stem Cells by Signaling-Directed Transcriptional Activation

Generation of Induced Pluripotent Stem Cells Using Recombinant Proteins.

The cytotoxic and immunogenic hurdles associated with non-viral mRNA-mediated reprogramming of human fibroblasts

Generation of human induced pluripotent stem cells using non-synthetic mRNA

Using Small Molecules to Improve Generation of Induced Pluripotent Stem Cells from Somatic Cells

RNA-based Reprogramming of Human Primary Fibroblasts into Induced Pluripotent Stem Cells

Reprogramming of Human Fibroblasts into Multipotent Cells with A Single Ecm Proteoglycan, Fibromodulin

Cell-free production of transducible transcription factors for nuclear reprogramming

Induction of Pluripotent Stem Cells from Mouse Embryonic Fibroblasts by Oct4 and Klf4 with Small-Molecule Compounds

A Combined Chemical and Genetic Approach for the Generation of Induced Pluripotent Stem Cells

A Transcriptional Roadmap to the Induction of Pluripotency in Somatic Cells

Feeder-Free Derivation of Human Induced Pluripotent Stem Cells with Messenger RNA

Reprogramming of mouse fibroblasts to an intermediate state of differentiation by chemical induction.

Generation of Human iPSCs by Reprogramming with the Unmodified Synthetic mRNA